Intel, Lenovo join forces with Huada Gene to accelerate genome analysis of new coronavirus

On March 3, Intel, Lenovo and Huada Genes announced today that they are working together to accelerate genomic profiling of the new CORONAvirus COVID-19. Experts from Intel and Lenovo will work together to provide researchers with new data analytics technologies and computing resources for researchers at Huada Gene to further enhance the analytical capabilities of their gene sequencing tools and to more efficiently study the genomic properties of new coronaviruses.

Original title: Intel, Lenovo join hands with Huada gene to accelerate the genome analysis of new coronavirus

Intel, Lenovo join forces with Huada Gene to accelerate genome analysis of new coronavirus

Huada DNBSEQ-T7 Sequencer (Huada Gene Supply)

Intel and Lenovo’s technology for Huada Gene includes a large, high-performance computing cluster that can be used to process high-throughput data read from Huada DNBSEQ-T7 sequencing systems. Huada Gene researchers will be able to further accelerate their study of the genomic characteristics of new coronaviruses through new high-performance computing and genomic analysis technologies, as well as the resources and expertise associated with Intel and Lenovo. The technology will enable scientists to study the virus’s toxicity, transmission patterns, and interactions between pathogens and hosts, which in turn will help epidemiological and vaccine design research. These efforts are essential for creating better diagnostic methods and designing effective vaccines or other protective measures in the future, such as immunotherapy.

Through this collaboration, Huada Gene will be able to continue to optimize its new coronavirus detection kits and obtain a wealth of valuable information. This information will help identify potential targets for the development of effective vaccines or treatments in the future. Through the joint efforts of Intel and Lenovo, Lenovo’s supercomputing technology supports and optimizes the Genomic Optimization and Scalability Tool (GOAST, the first genomic analysis tool validated by Intel’s ® select solutions), which can provide up to 40x 1 acceleration in genome-wide sequencing and all-exonic exon sequencing calculations. Help Huada gene optimize secomputing process, efficiently process data, and generate reliable genomic analysis results faster, reducing the time for scientific and clinical observation.

Intel, Lenovo join forces with Huada Gene to accelerate genome analysis of new coronavirus

The experimenter is operating the Huada DNBSEQ-T7 sequencer (Huada Gene Supply)

“There’s a lot we don’t know about this new coronavirus at the moment. Huada Gene accelerates the rapid identification and genomic characteristics of infected people by analyzing virus genome data, and these efforts require huge computational resources, which is where we can play a role. Wang Rui, vice president of Intel Marketing Group and general manager of China, said, “So we work closely together to provide more computing resources and professional support to scientists who are conducting virus research on the front line of epidemic prevention, hoping to fight the cunning virus to help prevent and control the outbreak and save more lives.” “

“The outbreak of new coronavirus pneumonia has touched the hearts of the people of the country, ” said Tong Fuxuan, senior vice president of Lenovo Group and president of Enterprise Technology Group. Lenovo, the world’s leading HPC manufacturer, is committed to providing computing support for life science research. Experts in big data analytics and health and life sciences from Intel and Lenovo will integrate our resources and expertise to help address today’s critical challenges and drive the development of health and life sciences. “

In genetic sequencing, each milliliter of body fluid typically contains millions of different viruses, and each virus’s genome contains about 30,000 DNA bases or letters. Huada Gene is genetic sequencing of many of the microbes of infected and suspected infected patients, so the work will generate a huge amount of data at the TB or even PB levels. To efficiently and quickly process this important data, more advanced HPC infrastructure, computing technology, and optimized genomic analysis methods are required.

Headquartered in Shenzhen, Huada Gene is one of the world’s leading companies focused on life sciences and genetic research. “Huada Gene has sequenced hundreds of clinical samples to analyze and distinguish between complications of infection,” said Jin Qiang, chief information officer of Huada Gene. Technology in the field of bioinformatics, such as genomic comparison, genome assembly, genomic annotation, and systematic analysis of viral nucleic acid fragments, is a high-density computational process, so adequate high-performance computing is critical to improving analytical efficiency. The ability to use the latest high-performance computing and genomic analysis techniques is an important factor in improving analytical efficiency. The device and technology will accelerate the rapid identification of new coronavirus infections and the study of viral genomic characteristics, providing strong support for the precise diagnosis, treatment and outbreak prevention and control of new coronaviruses. “